study	individual	count	intervention	measurement_type	substance	tissue	method	time	time_unit	value	median	min	max	cv	unit	comments
Lee2012	S23	1.0	GLI2	cmax	glimepiride	plasma	HPLC MS/MS	NA	NA	161.3	NA	NA	NA	NA	ng/ml	NA
Lee2012	S23	1.0	GLI2	tmax	glimepiride	plasma	HPLC MS/MS	NA	NA	3.0	NA	NA	NA	NA	hr	NA
Lee2012	S23	1.0	GLI2	thalf	glimepiride	plasma	HPLC MS/MS	NA	NA	2.9	NA	NA	NA	NA	hr	NA
Lee2012	S23	1.0	GLI2	oral-clearance	glimepiride	plasma	HPLC MS/MS	NA	NA	2401.3	NA	NA	NA	NA	ml/hr	NA
Lee2012	S23	1.0	GLI2	auc_end	glimepiride	plasma	HPLC MS/MS	12.0	hr	757.5	NA	NA	NA	NA	ng*hr/ml	NA
Lee2012	S23	1.0	GLI2	auc_inf	glimepiride	plasma	HPLC MS/MS	NA	NA	832.9	NA	NA	NA	NA	ng*hr/ml	NA
Lee2012	S21	1.0	GLI2	cmax	glimepiride	plasma	HPLC MS/MS	NA	NA	267.8	NA	NA	NA	NA	ng/ml	NA
Lee2012	S21	1.0	GLI2	tmax	glimepiride	plasma	HPLC MS/MS	NA	NA	4.0	NA	NA	NA	NA	hr	NA
Lee2012	S21	1.0	GLI2	thalf	glimepiride	plasma	HPLC MS/MS	NA	NA	12.3	NA	NA	NA	NA	hr	NA
Lee2012	S21	1.0	GLI2	oral-clearance	glimepiride	plasma	HPLC MS/MS	NA	NA	457.5	NA	NA	NA	NA	ml/hr	NA
Lee2012	S21	1.0	GLI2	auc_end	glimepiride	plasma	HPLC MS/MS	12.0	hr	1864.2	NA	NA	NA	NA	ng*hr/ml	NA
Lee2012	S21	1.0	GLI2	auc_inf	glimepiride	plasma	HPLC MS/MS	NA	NA	4371.9	NA	NA	NA	NA	ng*hr/ml	NA
